Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway
Atherosclerotic lesions are accelerated in patients with diabetes. M1 (classically activated in contrast to M2 alternatively activated) macrophages play key roles in the progression of atherosclerosis. Since advanced glycation end products (AGEs) are major pathogenic factors and active inflammation...
Main Authors: | Xian Jin, Tongqing Yao, Zhong’e Zhou, Jian Zhu, Song Zhang, Wei Hu, Chengxing Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/732450 |
Similar Items
-
Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
by: Zhong’e Zhou, et al.
Published: (2016-01-01) -
Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01) -
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
by: Stephen T. Buckley, et al.
Published: (2010-01-01) -
Interactions of the Receptor for Advanced Glycation End Products (Rage) with Advanced Glycation End Products (AGEs) and S100B
by: Indurthi, Venkata
Published: (2016) -
Rage (Receptor for Advanced Glycation End Products) in Melanoma Progression
by: Meghnani, Varsha
Published: (2018)